Lung Cancer
Favorable lung cancer prognosis linked to increased maspin gene expression
Published in Proteomics Weekly, May 22nd, 2006
"Maspin is a member of the serpin (serine protease inhibitor) superfamily, and some experimental studies revealed a potential tumor suppressor activity of maspin. To reveal clinical significance of maspin status in NSCLC, we quantitatively evaluated maspin gene expression in lung primary tumors cut from a total of 55 resected NSCLC patients," scientists writing in the journal Lung Cancer reported.
"Maspin expression in squamous cell carcinoma (Sq) was significantly higher than that in adenocarcinoma (Ad, p=.011). Five-year overall...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2006-05-22)
More Articles from Proteomics Weekly
- Angiology
Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells - Cardiomyocytes
During simulated ischemia, Bax translocates to mitochondria of heart cells - Proteomics
Gastric cancer multidrug resistance probed by proteome analysis - Proteomics
Human herpesvirus 6 U94/REP protein inhibits betaherpesvirus replication - Vaccine Development
Plasmid developed for rapid production of recombinant fused proteins in Escherichia coli - Allergy & Immunology
T cell factors are required for collagen type I-mediated activation of ERK/MAP kinase - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
